Hedge Funds Still Kind Of Bullish On AMAG Pharmaceuticals, Inc. (AMAG)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Posts Tagged ‘NASDAQ:AMAG’
Hedge Funds Are Souring On AMAG Pharmaceuticals, Inc. (AMAG)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Hedge Funds Are Still Bullish On AMAG Pharmaceuticals (AMAG)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Hedge Fund and Insider Trading News: Pentwater Capital, BlueMountain Capital, Elliott Management, Saba Capital Management, Harvest Capital Credit Corp (HCAP), Chewy Inc (CHWY), and More
US hedge fund Pentwater Capital has emerged as the buyer of the 23 per cent stake in Irish life science investment company Malin Corp that was sold in recent weeks by troubled...
Hedge Fund and Insider Trading News: T. Boone Pickens, Carl Icahn, Glen Kacher, Camber Capital Management, Elliott Management, Abbvie Inc. (ABBV), Fidelity National Financial Inc (FNF), and More
In a message he wrote shortly before his death, the legendary oil magnate T.
Hedge Fund and Insider Trading News: Bill Ackman, Stanley Druckenmiller, Starboard Value LP, Burlington Stores Inc (BURL), PVH Corp (PVH), Euronet Worldwide, Inc. (EEFT), and More
Pershing Square bucks a down market with August gains.
Hedge Fund and Insider Trading News: Daniel Loeb, Ray Dalio, Lone Pine Capital, Saba Capital Management, Kingstown Capital Management, Alphabet Inc (GOOGL), AMAG Pharmaceuticals Inc. (AMAG), and a Lot More
BOSTON (Reuters) - Billionaire investor Daniel Loeb said on Friday that his hedge fund Third Point LLC will vote against the planned merger of United Technologies Corp (UTX.N) ...
Here’s What Hedge Funds Think About AMAG Pharmaceuticals, Inc. (AMAG)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is AMAG Pharmaceuticals, Inc. (AMAG) A Good Stock To Buy?
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
13G Filing: Camber Capital Management and AMAG Pharmaceuticals Inc. (AMAG)
You can access the original SEC filing by clicking here.
13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG)
You can access the original SEC filing by clicking here.
13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG)
You can access the original SEC filing by clicking here.
Two Biotech Catalysts To Watch Right Now: Bioline RX Ltd (BLRX) And AMAG Pharmaceuticals, Inc. (AMAG)
It’s been a busy quarter in the biotechnology space, but it’s not over yet.
AMAG Pharmaceuticals, Inc. (AMAG), Palatin Technologies, Inc. (PTN) In Licensing Deal
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) and Palatin Technologies, Inc.
Is AMAG Pharmaceuticals, Inc. (AMAG) Going to Burn These Hedge Funds?
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
AMAG Pharmaceuticals, Inc. (AMAG) Is An Attractive Contrarian Entry
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) took a big hit yesterday, as the company announced its second-quarter earnings and missed on expectations – well, sort of.
Steven Cohen Reveals Bullish Bet On Amag Pharmaceuticals (AMAG), Shares Jump 6%
Billionaire Steven Cohen is bullish on Amag Pharmaceuticals Inc. (NASDAQ:AMAG), as his family office has disclosed a fresh stake in the company.
Healthinvest Partners’ Top Stock Picks For 2016
Sweden-based healthcare focused long/short equity hedge fund Healthinvest Partners AB was founded in 2006 by Anders Hallberg and Carl Bennet.
13G Filing: Billionaire David Shaw’s D. E. Shaw & Co. and AMAG Pharmaceuticals Inc. (AMAG)
D. E. Shaw Co., a fund founded by billionaire quant David Shaw, has disclosed its position in AMAG Pharmaceuticals, Inc.
Why These 4 Stocks Have Started the Week Off on the Right Foot
The markets have continued to tumble in the second week of 2016, with all major U.S stock indexes now down today after a mild rally earlier in the day.
Do Hedge Funds Love AMAG Pharmaceuticals, Inc. (AMAG)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
The Shoddy Results That Have These Four Stocks Plunging Today
The shareholders of CIT Group Inc. (NYSE:CIT), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Avis Budget Group Inc.
Should You Follow This Investor Into His Biotech Picks?
For the last year or so, many investors have been seeking profitable opportunities in the biotech sector, which has sent the shares of many stocks higher.
These Hot Healthcare Stocks Lead Palo Alto Investors’ Picks To Big Q2 Returns
William Leland Edwards' Palo Alto Investors is a reputable fund with a strong focus and in-depth knowledge of healthcare stocks, a sector that accounts for more than 80% of ...
Volcano Corporation (VOLC), Relypsa Inc (RLYP), Inogen Inc (INGN):5 Small-Cap Healthcare Stocks Hedge Funds Are Flocking To
Our research has shown us that hedge funds are particularly adept at generating large returns from small-cap stocks.
AMAG Pharmaceuticals Inc. (AMAG): Deerfield Management Boosts Stake to Nearly 6%
Deerfield Management, managed by James E. Flynn, has disclosed upping its stake in AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). A new filing with the U.S.
Broadfin Capital Initiates New Positions In Corium International Inc (CORI), AMAG Pharmaceuticals Inc. (AMAG) and La Jolla Pharmaceutical Company (LJPC)
In three recent filings, Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals Inc.
Visium Asset Management’s Latest Purchase: AMAG Pharmaceuticals Inc. (AMAG)
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc.
Meridian Bioscience, Inc. (VIVO): Are Hedge Funds Right About This Stock?
In the 21st century investor’s toolkit, there are many methods shareholders can use to track publicly traded companies.
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling
If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age.
Abaxis Inc (ABAX): Insiders Aren’t Crazy About It
In today’s marketplace, there are many metrics investors can use to watch stocks. Two of the most under-the-radar are hedge fund and insider trading activity.
Hedge Funds Aren’t Crazy About Quidel Corporation (QDEL) Anymore
In today’s marketplace, there are many indicators shareholders can use to watch the equity markets.
This Metric Says You Are Smart to Buy Trinity Biotech plc (ADR) (TRIB)
If you'd ask most market participants, hedge funds are seen as slow, outdated investment vehicles of years past.
Do Hedge Funds and Insiders Love SurModics, Inc. (SRDX)?
SurModics, Inc. (NASDAQ:SRDX) was in 8 hedge funds' portfolio at the end of March.
How Are Hedge Funds Trading AMAG Pharmaceuticals, Inc. (AMAG)?
Is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) the right pick for your portfolio? Prominent investors are taking a pessimistic view.
Hedge Funds Are Crazy About Synta Pharmaceuticals Corp. (SNTA)
In the eyes of most investors, hedge funds are assumed to be underperforming, old financial vehicles of years past.
Ironwood Pharmaceuticals, Inc. (IRWD), Forest Laboratories, Inc. (FRX): Three Horrendous Healthcare Stocks This Past Week
Gloom, despair, and agony. Shareholders of at least three health-care stocks experienced one or more of these feelings over the past few days.
Should You Avoid AMAG Pharmaceuticals, Inc. (AMAG)?
Is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) a good investment today? Investors who are in the know are taking a pessimistic view.
Hedge Funds Are Dumping Trinity Biotech plc (ADR) (TRIB)
Is Trinity Biotech plc (ADR) (NASDAQ:TRIB) a sound investment now? Hedge funds are reducing their bets on the stock.
SurModics, Inc. (SRDX): Insiders Are Dumping, Should You?
Is SurModics, Inc. (NASDAQ:SRDX) worth your attention right now? Hedge funds are in a pessimistic mood.
This Metric Says You Are Smart to Buy Synta Pharmaceuticals Corp. (SNTA)
In the 21st century investor’s toolkit, there are plenty of metrics shareholders can use to monitor their holdings.
